A rapid and sensitive ESI-MS screening procedure for ketamine and norketamine in urine samples

Journal of Analytical Toxicology

Volumn 28, Issue 8, 2004, Pages 680-684

  Lua, Ahai C ^a   Lin, Huei R ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; NORKETAMINE; UNCLASSIFIED DRUG;

ACCURACY; CONFERENCE PAPER; ELECTROSPRAY; HUMAN; ION TRAP MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY; STANDARD; URINALYSIS;

EID: 8444252940     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.8.680     Document Type: Conference Paper

References (26)

1. E.F. Domino, P. Chodoff, and G. Corssen. Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin. Pharmacol. Ther. 40: 279-291 (1965).
2. P.F. White, W.L. Way, and A.J. Trevor. Ketamine: its pharmacology and therapeutic uses. Anesthesiology 56: 119-136 (1982).
3. S.N. Ahmed and L. Petchkovsky. Abuse of ketamine. Br. J. Psychiatry 137: 303 (1980).
4. M. Licata, G. Pierini, and G. Popoli. A fatal ketamine poisoning. J. Forensic Sci. 39: 1314-1320 (1994).
5. P.J. Dalarno and D. Shewan. Illicit use of ketamine in Scotland. J. Psychoactive Drugs. 28: 191-199 (1996).
6. K.A. Moore, E.M. Kilbane, R. Jones, C.W. Kunsman, B. Levine, and M. Smith. Tissue distribution of ketamine in a mixed drug fatality. J. Forensic Sci. 42: 1183-1185 (1997).
7. N.N. Moore and J.M. Bostwick. Ketamine dependence in anesthesia providers. Psychosomatics 40: 356-359 (1999).
8. J.R. Gill and M. Stajic. Ketamine in non-hospital and hospital deaths in New York City. J. Forensic Sci. 45: 655-658 (2000).
9. K.A. Moore, J. Sklerov, B. Levine, and A.J. Jacobs. Urine concentrations of ketamine and norketamine following illegal consumption. J. Anal. Toxicol. 25: 583-588 (2001).
10. A.C. Lua, H.R. Lin, Y.T. Tseng, A.R. Hu, and P.C. Yeh. Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse. Forensic Sci. Int. 136: 47-51 (2003).
11. J.A. Clements and W.S. Nimmo. Pharmacokinetics and analgesics effect of ketamine in man. Br. J. Anaesth. 53: 27-30 (1981).
12. B.R. Lalonde and H.R. Wallage. Postmortem blood ketamine distribution in two fatalities. J. Anal. Toxicol. 28: 71-74 (2004).
13. R.L. Stiller, P.G. Dayton, J.M. Perel, and C.C. Hug, Jr. Gas chromatographic analysis of ketamine and norketamine in plasma and urine: nitrogen-sensitive detection. J. Chromatogr. 232: 305-314 (1982).
14. S.H. Peyton, A.T. Couch, and R.O. Bost. Tissue distribution of ketamine: two case reports. J. Anal. Toxicol. 12: 268-269 (1988).
15. H.R. Lin and A.C. Lua. Detection of acid-labile conjugates of ketamine and its metabolites in urine samples collected from pub participants. J. Anal. Toxicol. 28: 181-186 (2004).
16. M. Rittner, F. Pragst, W.R. Bork, and J. Newmann. Screening methods for seventy psychoactive drugs or drug metabolites in serum based on high-performance liquid chromatography-mass spectrometry ionization mass spectrometry. J. Anal. Toxicol. 25: 115-124 (2001).
17. H.K. Nordgren and O. Beck. Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 27: 15-19 (2003).
18. V. Cirimele, M. Villain, C. Pepin, B. Ludes, and P. Kintz. Screening procedure for eight quaternary nitrogen muscle relaxants in blood by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 789: 107-113 (2003).
19. W. Weinmann and M. Svoboda. Fast screening for drugs of abuse by solid-phase extraction combined with flow-injection ionspray-tandem mass spectrometry. J. Anal. Toxicol. 22: 319-328 (1998).
20. J. Zweigenbaum, K. Heinig, S. Steinborner, T. Wachs, and J. Henion. High throughput bioanalytical LC/MS/MS determination of benzodiazepines in human urine: 1000 samples per 12 hours. Anal. Chem. 71: 2294-2300 (1999).
21. A.H.B. Wu, T.A. Onigbinde, S.S. Wong, and K.G. Johnson. Evaluation of full-scanning GC/ion trap MS analysis of NIDA drugs of abuse urine testing in urine. J. Anal. Toxicol. 16: 202-206 (1992).
22. A. Ramseier, C. Siethoff, J. Caslavska, and W. Thormann. Confirmation testing of amphetamines and designer drugs in human urine by capillary electrophoresis-ion trap mass spectrometry. Electrophoresis 21: 380-387 (2000).
23. C.H.M. Kerskes, K.J. Lusthof, P.G.M. Zweipfenning, and J.P. Franke. The detection and identification of quaternary nitrogen muscle relaxants in biological fluids and tissue by ion-trap LC-ESI-MS. J. Anal. Toxicol. 26: 29-34 (2002).
24. M.J. Cole, J.S. Janiszewski, and H.G. Fouda. Electrospray mass spectrometry in contemporary drug metabolism and pharmacokinetics. In Electrospray Ionization Mass Spectrometry, B.N. Pramanik, A.K. Ganguly, and M.L. Gross, Eds. Marcel Dekker, New York, NY, 2002, pp 211-249.
25. R.H. Liu. Evaluation of common immunoassay kits for effective workplace drug testing. In Handbook of Workplace Drug Testing, R.H. Liu and B.A. Goldberger, Eds. AACC Press, Washington, D.C., 1995, pp 67-129.
26. P.R. Stout, C.K. Horn, and K.L. Klette. Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphtamine in urine by soild-phase extraction and GC-MS: a method optimized for high volume laboratories. J. Anal. Toxicol. 26: 253-261 (2002).